Searched for
ANKYLOSING SPONDYLITIS
Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- Biocon Biologics launches product for autoimmune diseases in AustraliaBiocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating autoimmune di...
- How an extremely busy Hyderabad doctor lost 30 kg weight. He started his fitness journey at 50 then completed 133 half marathonsAt 49, Hyderabad-based neurologist Dr. Sudhir Kumar was overweight, battling ankylosing spondylitis, and struggling with poor lifestyle hab...
- Zydus Lifesciences shares in focus after USFDA nod for Celecoxib capsulesZydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will manufacture the drug...
- Genetic study finds high inbreeding rates in South Indian communitiesA study of South Indian populations reveals a nearly 60% inbreeding rate due to endogamy, linked to increased genetic disorder risks. Resea...
- Biocon Biologics grants Sandoz exclusive rights to market biosimilar adalimumab in JapanAdalimumab BS for subcutaneous injection is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylos...
- Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drugZydus Lifesciences has gained the US Food and Drug Administration's (FDA) approval to produce and market its Indomethacin suppositories. Th...
- Alkem subsidiary Enzene launches adalimumab biosimilar in IndiaEnzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.
- Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsulesThe company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200...
- Morning stiffness, hurting joints? Reverse the discomfort with healthy diet, proper sleep and yogaKeeping bedroom warm, letting go of stress and relaxing before falling asleep can work wonders.
- Back pain & stiffness? Ankylosing Spondylitis is the kind of arthritis that strikes when you're youngInitial symptoms may not appear alarming, but they can be serious.
- Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in JapanMumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...
- Reliance Life gains global rights for copies of InfliximabFor Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...
- Torrent Pharma launches Adalimumab biosimilar in IndiaThe company's product will be available as pre-filled syringe of 40 mg, Torrent Pharmaceuticals said in a statement.
- India needs predictable IPR regime: NovartisThe Department of Industrial Policy and Promotion is expected to soon take the draft IPR policy to the Cabinet for approval.
- Mumbai doctors perform rare surgery on Bamboo Spine patientA team of doctors at a city hospital here have performed minimal access spine surgery on an 82-year -old 'Ankylosing Spondylitis' patient.
- Ranbaxy launches arthritis drug Infimab in IndiaInfimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...
- Lupin gets USFDA nod for arthritis drugThe company has also received tentative approvals for its product in strengths of 100 mg, 200 mg and 400 mg from the FDA.
- Cipla launches biosimilar for rheumatic disorders in IndiaDrug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...
Load More
